Back to the Colorectal Cancer Consensus Molecular Subtype Future

Area of Science:

• Oncology
• Genomics
• Bioinformatics

Background:

• Colorectal cancer (CRC) is a complex disease with diverse molecular alterations.
• Understanding these alterations is crucial for effective treatment and prognosis.

Purpose of the Study:

• To review advances in molecular profiling and analysis of colorectal cancer.
• To provide historical context and current summary of bioinformatic progress in CRC research.

Main Methods:

• Review of gene and protein sequencing technologies.
• Analysis of computational capabilities driving bioinformatic advancements.

Main Results:

• Significant knowledge explosion regarding genetic, epigenetic, and biochemical changes in CRC.
• CRC is recognized as a heterogeneous disease where molecular subtypes influence clinical course and treatment response.
• The Consensus Molecular Subtypes (CMS) classification identifies four distinct subtypes with potential for clinical stratification and targeted interventions.

Conclusions:

• Molecular subtyping of CRC is essential for identifying specific therapeutic targets.
• Advances in molecular analysis and bioinformatics are paving the way for personalized CRC treatment strategies.